Clinical trials
Phase 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2020 | 2 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| AbbVie | 1 |
| Allotera Therapeutics | 1 |
| AstraZeneca | 1 |
| Biomea Fusion Inc. | 1 |
| Children's Oncology Group | 1 |
| Epizyme, Inc. | 1 |
| Medigene AG | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 10 |
| Leukemia, Myeloid, Acute | 5 |
| Leukemia | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Multiple Myeloma | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Myelodysplastic Syndromes | 2 |
| Myeloproliferative Disorders | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.